Streetbeat News

Equity Actions

AVGO

Broadcom (NASDAQ:AVGO) has seen a significant amount of options activity, indicating a bearish stance by big-money investors. Benzinga's options scanner revealed 191 unusual trades, with a sentiment split of 29% bullish and 70% bearish. The trades suggest a price target range of $800 to $2100 for AVGO over the next three months. Notable options activity includes both calls and puts with various expiration dates and strike prices. Broadcom, a major player in the semiconductor and software industries, has seen its stock price increase by 0.99% to $1364.96. Market experts have issued ratings with a consensus target price of $1570.0.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:30 pm

LVS

Las Vegas Sands Corp. (NYSE:LVS) shares rose amid news of Macau's recovery, with Mizuho Securities highlighting the company's potential to benefit from the market's mass recovery. Analyst Ben Chaiken initiated coverage with a Buy rating and a $70 price target, citing strategic investments in Macau and Singapore and the potential for significant share repurchases over the next three years.

Portfolio Pulse from Priya Nigam

March 26, 2024 | 3:27 pm

EFSH

1847 Holdings LLC (EFSH) has requested the withdrawal of its Registration Statement on Form S-3, initially filed on February 1, 2023, with no shares sold under this statement. The company emphasizes its focus on building value within its portfolio, highlighting recent developments with ICU Eyewear, Signature Home Craft, and Wolo Manufacturing. These initiatives aim to enhance shareholder value and reflect the company's strategy of acquiring and improving small companies for higher valuations through sales or IPOs.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 3:04 pm

SNX

TD SYNNEX shares surged following the announcement of higher-than-expected Q1 revenues and a new $2 billion share repurchase authorization.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 3:03 pm

PENN

Analysts have diverse opinions on PENN Entertainment (NASDAQ:PENN), with recent evaluations showing a mix of bullish to bearish sentiments. The average 12-month price target is $26.83, down from $29.00, indicating a negative outlook. PENN's financial performance shows challenges, including a -12.0% revenue decline and below-industry benchmarks in profitability and debt management. The company operates 43 properties across 20 states, with a significant portion of sales from land-based casinos.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:00 pm

BOKF

V

BOK Financial Corp is expected to participate in the share exchange offer recently announced by Visa Inc, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:12 pm

MOV

Movado Group Inc. (NYSE:MOV) shares fell after reporting Q4 earnings that beat expectations but provided a weaker FY25 EPS outlook than consensus. Despite beating Q4 earnings and revenue forecasts, the company's adjusted operating income declined year-over-year, and its FY25 EPS guidance of $1.20-$1.30 is significantly below the consensus of $2.06. Movado also announced a dividend payment and share repurchase progress, expecting flat net sales for the first half of FY25.

Portfolio Pulse from Nabaparna Bhattacharya

March 26, 2024 | 2:02 pm

REGN

Analysts have provided diverse opinions on Regeneron Pharmaceuticals (NASDAQ:REGN) with a mix of bullish to bearish ratings over the past quarter. The average 12-month price target for REGN has been raised to $1068.58, indicating a positive outlook. The company's financials show a market capitalization above industry average, but it lags in revenue growth, net margin, ROE, and ROA compared to its peers. However, its low debt-to-equity ratio is seen positively.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:01 pm

VAC

Marriott Vacations (NYSE:VAC) received mixed ratings from 7 analysts, with an updated average 12-month price target of $115.43, marking a 9.52% increase from the previous target. The company operates in the leisure industry, primarily in the US, and has shown a revenue growth of 0.51% as of December 31, 2023. However, it faces challenges in profitability, asset utilization, and shareholder returns, with below-industry averages in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:00 pm

CLX

In the last three months, Clorox (NYSE:CLX) received 6 analyst ratings, showing a shift towards a neutral stance with 4 indifferent ratings recently. The average 12-month price target for Clorox is now $147.83, up 9.5% from the previous $135.00, with a high estimate of $170.00 and a low of $118.00. Analysts from firms like Jefferies, Goldman Sachs, DA Davidson, UBS, JP Morgan, and Barclays have updated their ratings and price targets, reflecting changes in market conditions and Clorox's performance. Clorox's financial performance shows a notable revenue growth of 16.04% as of December 31, 2023, but challenges in net margin, debt management, and ROA, despite an exceptional ROE of 1162.5%.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:00 pm